loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for cep_2023_104___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City CN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

Looking for Certificates of Suitability (CEPs) for CEP 2023-104 - Rev 00 of Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn

Looking for Certificates of Suitability (CEPs) for CEP 2023-104 - Rev 00 of Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn 1

20

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Cladribine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-104 - Rev 00

This Chemical Type CEP, issued on April 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2174 associated with this CEP further emphasizes